Cappel R, DeCuyper F, Van Beers D
J Infect Dis. 1977 Nov;136(5):617-22. doi: 10.1093/infdis/136.5.617.
A high positive correlation was found between e antigen (HBe Ag) and DNA polymerase in hemodialyzed patients with acute hepatitis B, chronic carriers of hepatitis B surface antigen undergoing hemodialysis, and patients with chronic hepatitis. In contrast, the correlation was poor in nonhemodialyzed patients with acute hepatitis. Among the patients with chronic hepatitis, HBe Ag and DNA polymerase were were found mostly in those with aggressive hepatitis and rarely in those with persistent hepatitis. This difference was significant (P less than 0.01) and suggests that the persistence of these antigens may be a factor in the progression of the disease. Our data also indicate that the development of antibodies to HBe Ag (anti-HBe) might be a sign of a favorable prognosis, since 50% of the patients with persistent hepatitis vs. 6% of the patients with aggressive hepatitis were anti-HBe-positive. Inhibitors of DNA polymerase, which are possibly antibodies, appeared regularly after acute hepatitis and were transient. Their presence may be associated with viral replication.
在接受血液透析的急性乙型肝炎患者、接受血液透析的慢性乙型肝炎表面抗原携带者以及慢性肝炎患者中,发现e抗原(HBe Ag)与DNA聚合酶之间存在高度正相关。相比之下,未接受血液透析的急性肝炎患者中这种相关性较差。在慢性肝炎患者中,HBe Ag和DNA聚合酶主要见于侵袭性肝炎患者,而在持续性肝炎患者中很少见。这种差异具有显著性(P小于0.01),提示这些抗原的持续存在可能是疾病进展的一个因素。我们的数据还表明,HBe Ag抗体(抗-HBe)的出现可能是预后良好的标志,因为持续性肝炎患者中有50%抗-HBe呈阳性,而侵袭性肝炎患者中这一比例为6%。DNA聚合酶抑制剂可能是抗体,在急性肝炎后经常出现且为一过性。它们的存在可能与病毒复制有关。